NeoGenomics’ PanTracer LBx Test Qualifies for Medicare Coverage Under MolDX Policy
The blood-based genomic profiling assay for advanced solid tumors is now reimbursable under Medicare’s policy covering plasma-based genomic profiling tests.
Category: Lab Management
Lab Management
Latest
Lab Management
Latest
Illumina Secures CMS Reimbursement for TruSight Oncology Test
Illumina’s FDA-approved TruSight Oncology test will be reimbursed by CMS at $2,989.55 per test starting Jan. 1, 2026, enabling broader laboratory access to genomic profiling for Medicare beneficiaries.
Lab Management
Latest
Lab Sets Guinness World Record for DNA Sequencing Speed
Teams complete whole human genome sequencing and analysis in under four hours, demonstrating potential for same-day NICU workflows.
Accreditation
Latest
LuminoDx Earns CAP Accreditation for Diagnostic Testing Facility
The accreditation covers liver health diagnostics, including Hepatotrack, a molecular diagnostic liquid biopsy that is predictive of acute liver rejection post-liver transplant.
Compliance
Latest
Proscia Earns SOC 2 Type II Certification for Digital Pathology Platform
The compliance milestone adds to the company's existing ISO certifications as enterprise deployments accelerate across pharmaceutical and diagnostic laboratory customers.
Proficiency Testing
Latest
Managing Reagent Variation
Lot-to-lot reagent inconsistencies can have significant effects on patient test results.
Company News
Latest
Proposed Acquisition Positions Inspira to Enter Liquid Biopsy Diagnostics Market
The Israel-based company has signed a non-binding term sheet to acquire a liquid biopsy diagnostics platform and secure a concurrent $15 million strategic equity investment.
Resource Center
Latest
Global Study Reveals Escalating Antimicrobial Resistance Patterns
Analysis of international surveillance data shows rising resistance to last-line antibiotics, with significant regional variations in treatment outcomes.